06R10JZ
Replacement Splenic Vein to No Qualifier with Synthetic Substitute, Open Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 6 Lower Veins |
| Operation | R Replacement |
| Body Part | 1 Splenic Vein |
| Approach | 0 Open |
| Device | J Synthetic Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically takes the place and/or function of all or a portion of a body part
Procedure Overview
This family covers procedures where a diseased or damaged segment of a lower-body vein - in the leg, pelvis, or abdomen - is physically removed and replaced with another material that takes over its job of carrying blood back toward the heart. The replacement material can be a graft harvested from the patient's own body, tissue from a donor or animal source that has been processed for implantation, or a synthetic conduit made from materials like expanded PTFE. It is most often considered when a vein segment is too scarred, obstructed, or aneurysmal to repair in place.
Surgeons turn to this approach in situations such as reconstructing a badly damaged femoral or iliac vein after trauma, cancer resection that required removing a vein along with a tumor, or chronic venous disease that has destroyed a segment beyond salvage. The goal is to restore a functioning channel for venous return rather than simply tying off the vessel, which can be important for preventing long-term swelling and pressure buildup in the limb.
Because deep veins carry a large volume of blood at low pressure, these reconstructions are technically demanding and are typically reserved for cases where the alternative - vein ligation or leaving the segment untreated - would cause significant disability.
Anatomy & Axis Detail
Splenic Vein
The splenic vein runs along the posterior pancreas and drains the spleen and portions of the stomach and pancreas into the portal system, making it vulnerable to compression or invasion by pancreatic tumors, pancreatitis-related thrombosis, or splenic pathology. Replacement of a diseased segment with a graft is a technically demanding step within larger pancreatic or splenic resections, undertaken when the vessel cannot simply be repaired or ligated without compromising portal inflow and risking left-sided portal hypertension. Its close anatomic relationship to the pancreatic tail and portal confluence means replacement is rarely an isolated operation, and documentation should reflect its role within the broader procedure, such as pancreatectomy with vascular reconstruction.
Approach: Open
Open approach means the surgeon cuts through skin, mucous membrane, or other tissue layers to physically expose the target site to view before performing the procedure. It gives direct visualization and hands-on access, distinguishing it from Percutaneous approaches where instruments pass through a small puncture without exposing the site. Open is typical for procedures needing wide access, such as most laparotomies.
Device: Synthetic Substitute
Synthetic Substitute designates a device made from manufactured, non-biologic material, such as mesh or prosthetic components, used to replace or augment a body part. It is distinguished from the two tissue substitute categories by its artificial composition, which carries different considerations for integration and long-term durability than biologic grafts.
Coding & Documentation
A code from this family requires documentation that a vein segment was excised or entirely taken out of the body and replaced with graft material, not simply patched, bypassed, or reinforced on its outer surface. The operative note should specify the exact vein involved (e.g., common femoral vein versus external iliac vein) and the type of material used, since device value selection depends on whether the graft is autologous tissue, nonautologous tissue, or synthetic.
The most common assignment error is confusing Replacement with Supplement or Bypass. If the native vein is left in place and the graft material is only added to reinforce or widen it, Supplement applies instead. If the graft creates an alternate route around a blocked segment while the diseased vein remains, that is a Bypass procedure, not Replacement. Coders should also confirm the qualifier for autologous versus nonautologous tissue, which is frequently omitted or guessed rather than confirmed from the documentation.